BIO vs SNPS · rev $2.58B vs P/E 63, rev $7.16B
BIO (BIO) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 287.0% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
BIO currently screens at market cap $0. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the BIO and SNPS stock pages for the full models.
Not investment advice.